Danish allergy group ALK has invested more efforts than ever in simplifying processes and streamlining the company. The changes involve expenses in the short-term but will hopefully help ALK fulfill the long-term goal to match other pharma companies.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.